13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$1.00T
−20% on the quarter before
Positions
5,351
388 new · 471 sold out
Top 10
26.1%
of the value
Est. gain
−$222.65B
on stocks held all quarter
Est. return
−19.1%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 36% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$1.60BAdded · 0.1% → 0.2%+15,041,149 shares
- Exxon Mobil Corp~$1.50BAdded · 0.8% → 1.2%+17,521,080 shares
- Coca Cola Co~$1.04BAdded · 0.4% → 0.6%+16,606,701 shares
- Vertex Pharmaceuticals Inc~$1.01BAdded · 0.3% → 0.5%+3,571,298 shares
- Occidental Pete Corp~$938.3MAdded · 0.0% → 0.1%+15,936,636 shares
- Charter Communications Inc N~$890.2MAdded · 0.0% → 0.1%+1,899,927 shares
- Comcast Corp New~$794.7MAdded · 0.3% → 0.4%+20,251,251 shares
- Conocophillips~$747.5MAdded · 0.1% → 0.2%+8,323,587 shares
- Lockheed Martin Corp~$731.6MAdded · 0.2% → 0.3%+1,701,615 shares
- Merck & Co Inc~$712.6MAdded · 0.1% → 0.2%+7,816,470 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$2.53BCut · 2.9% → 2.6%−1,159,227 shares
- Salesforce~$1.94BCut · 1.0% → 0.8%−11,742,745 shares
- Adobe~$1.19BCut · 0.6% → 0.5%−3,238,307 shares
- Alphabet~$1.18BCut · 1.7% → 1.5%−539,676 shares
- Altria Group Inc~$1.13BCut · 0.2% → 0.1%−27,172,023 shares
- Meta~$1.12BCut · 2.2% → 1.9%−6,944,228 shares
- Intuitive Surgical~$1.11BCut · 0.3% → 0.1%−5,533,570 shares
- Apple~$993.5MCut · 4.9% → 4.7%−7,266,788 shares
- Microsoft~$807.2MCut · 5.2% → 5.3%−3,143,054 shares
- Home Depot Inc~$718.1MCut · 0.4% → 0.4%−2,618,084 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.5% · price −16.7% | 5.3% | $53.22B | −$10.67B | ||||||||
| AppleCOM · shares −2.1% · price −21.7% | 4.7% | $47.08B | −$13.05B | ||||||||
| AmazonCOM · shares −0.4% · price −38.1% | 3.0% | $30.38B | −$18.70B | ||||||||
| AlphabetCAP STK CL A · shares −8.8% · price −21.6% | 2.6% | $26.08B | −$7.21B | ||||||||
| Unitedhealth Group IncCOM · shares +2.0% · price +0.7% | 2.5% | $25.59B | +$178.7M | ||||||||
| NvidiaCOM · shares −3.0% · price −44.4% | 2.1% | $21.32B | −$17.06B | ||||||||
| MetaCL A · shares −5.7% · price −27.5% | 1.9% | $18.67B | −$7.08B | ||||||||
| AlphabetCAP STK CL C · shares −7.1% · price −21.7% | 1.5% | $15.39B | −$4.26B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares −0.02% · price −22.7% | 1.3% | $12.98B | −$3.81B | ||||||||
| Exxon Mobil CorpCOM · shares +15% · price +3.7% | 1.2% | $11.57B | +$358.7M | ||||||||
| Eli LillyCOM · shares +2.9% · price +13.2% | 1.0% | $10.52B | +$1.19B | ||||||||
| Visa Inc.COM CL A · shares −2.5% · price −11.2% | 0.95% | $9.57B | −$1.21B | ||||||||
| SalesforceCOM · shares −19% · price −22.3% | 0.81% | $8.08B | −$2.32B | ||||||||
| TeslaCOM · shares +3.1% · price −37.5% | 0.79% | $7.97B | −$4.64B | ||||||||
| MastercardCL A · shares −3.1% · price −11.7% | 0.76% | $7.61B | −$1.01B | ||||||||
| Bk Of America CorpCOM · shares +3.9% · price −24.5% | 0.70% | $7.01B | −$2.19B | ||||||||
| Wells Fargo Co NewCOM · shares −2.1% · price −19.2% | 0.70% | $7.01B | −$1.66B | ||||||||
| Danaher CorporationCOM · shares +0.8% · price −13.6% | 0.64% | $6.47B | −$1.01B | ||||||||
| Coca Cola CoCOM · shares +20% · price +1.5% | 0.62% | $6.27B | +$75.6M | ||||||||
| Regeneron PharmaceuticalsCOM · shares +1.9% · price −15.4% | 0.60% | $6.02B | −$1.07B | ||||||||
| Bristol-Myers Squibb CoCOM · shares +7.2% · price +5.4% | 0.55% | $5.53B | +$266.1M | ||||||||
| Marvell Technology IncCOM · shares +3.0% · price −39.3% | 0.54% | $5.43B | −$3.41B | ||||||||
| Thermo Fisher Scientific IncCOM · shares −3.1% · price −8.0% | 0.54% | $5.42B | −$472.9M | ||||||||
| AdobeCOM · shares −18% · price −19.7% | 0.53% | $5.27B | −$1.29B | ||||||||
| Lululemon Athletica IncCOM · shares −1.0% · price −25.4% | 0.50% | $5.02B | −$1.71B | ||||||||
| Total · 5,351 positions | 100% | $1.00T | −$222.65B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 4,415 stocks held throughout, down $222.65B (−19.1%).
- Eli Lilly+$1.19B+13%
- PDD Holdings+$474.2M+54%
- Exxon Mobil Corp+$358.7M+4%
- Monster Beverage Corp New+$330.8M+16%
- Cigna Corp New+$317.2M+10%
- Alphabet−$7.21B−22%
- Microsoft−$10.67B−17%
- Apple−$13.05B−22%
- Nvidia−$17.06B−44%
- Amazon19:1 split−$18.70B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 45 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |